Chronic Plaque Psoriasis, Metastatic Prostate Cancer And Onychomycosis (Tinea Unguium) Review Up To 2015: Radiant Insights

Radiant Insights
RadiantInsights.com includes new market research report on ‚ÄúChronic Plaque Psoriasis, Metastatic Prostate Cancer And Onychomycosis (Tinea Unguium) Review Up To 2015″ to its huge collection of research reports.

Chronic Plaque Psoriasis – Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Chronic Plaque Psoriasis – Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

• The report provides a snapshot of the global therapeutic landscape of Chronic Plaque Psoriasis

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Chronic Plaque Psoriasis and enlists all their major and minor projects


For more Information About Chronic Plaque Psoriasis – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/chronic-plaque-psoriasis-pipeline-review-h1-2015

Metastatic Prostate Cancer – Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Metastatic Prostate Cancer – Pipeline Review, H1 2015’, provides an overview of the Metastatic Prostate Cancer’s therapeutic pipeline.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

• The report provides a snapshot of the global therapeutic landscape of Metastatic Prostate Cancer

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Metastatic Prostate Cancer and enlists all their major and minor projects


For more Information About 
Metastatic Prostate Cancer – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/metastatic-prostate-cancer-pipeline-review-h1-2015

Onychomycosis (Tinea Unguium) – Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) – Pipeline Review, H1 2015’, provides an overview of the Onychomycosis (Tinea Unguium)’s therapeutic pipeline.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

Scope

• The report provides a snapshot of the global therapeutic landscape of Onychomycosis (Tinea Unguium)

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics development for Onychomycosis (Tinea Unguium) and enlists all their major and minor projects


For more Information About 
Onychomycosis (Tinea Unguium) – Pipeline Review, H1 2015 Click:
http://www.radiantinsights.com/research/onychomycosis-tinea-unguium-pipeline-review-h1-2015

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For more information, visit: http://www.radiantinsights.com/

Blog URL: http://www.terrapass.org/

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: Send Email
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/chronic-plaque-psoriasis-pipeline-review-h1-2015